| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VERTEX PHARMACEUTICALS INC / MA
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Kewalramani Reshma | 110.3K | $51.81M | - |
| VP | Sachdev Amit | 68.5K | $32.18M | - |
| COO | Arbuckle Stuart A | 63.4K | $29.78M | - |
| CFO | WAGNER CHARLES F JR | 51.7K | $24.28M | - |
| VP | 47.3K | $22.21M | -9,532 |
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2019-05-15 | Kewalramani Reshma | EVP and CMO | Sell | 241 | $165.41 | $39,863.81 | -1.7% | → |
| 2019-05-15 | Arbuckle Stuart A | EVP\Chief Commercial Officer | Sell | 133 | $165.41 | $21,999.53 | -0.4% | → |
| 2019-05-15 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 91 | $165.41 | $15,052.31 | -0.3% | → |